RPS12 antibodies are immunological tools designed to detect and study the ribosomal protein S12, a component of the 40S small ribosomal subunit. These antibodies are widely used in research to investigate RPS12's role in translation, hematopoiesis, and diseases such as Diamond-Blackfan Anemia (DBA) .
RPS12 antibodies are validated for multiple applications across species, including:
RPS12 antibodies exhibit broad species reactivity:
The epitope for most antibodies maps to residues 1–50 of human RPS12 (UniProt ID: P25398) .
Erythropoiesis Block: Rps12 heterozygous mice exhibit defective transitions from RII to RIII erythroblast stages, mirroring DBA pathology .
HSC Impairment: Reduced long-term hematopoietic stem cells (LT-HSCs) and pancytopenia observed in Rps12 KO/+ mice .
Acute RPS12 depletion reduces global translation, while chronic heterozygosity upregulates compensatory pathways .
RpS12 in Drosophila modulates Xrp1 activity, affecting cell competition and developmental rates .
Current RPS12 antibodies lack validation in non-model organisms (e.g., zebrafish, C. elegans). Further studies are needed to explore:
RPS12’s role in mitochondrial ribosomes.
Therapeutic targeting in DBA and cancers.